No conflict of interest

Slides:



Advertisements
Similar presentations
Alfredo ALBERTI. How to predict outcome in hepatitis C patients Alfredo Alberti Department of Clinical and Experimental Medicine Venetian Institute of.
Advertisements

Jayaweera DT, Campa A, Casillas VJ, Martinez SS, Shin DH, Li Y, Young S, Baum MK.
Paul Calès Conflict of interest: FibroMeter
Diagnostic Accuracy of Serum Hyaluronic Acid for Advanced Fibrosis/Cirrhosis in Patients Coinfected with HIV and HCV S. Resino,* 1 P. Miralles, 2 D. Micheloud,
Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The.
Liver Fibrosis Are Non-invasive markers sufficient? William Rosenberg Prof of Hepatology University of Southampton CSO iQur Limited; Consultant to Bayer.
STEATO-HEPATITIS IN OBESE PATIENTS SUBMITTED TO BARIATRIC SURGERY (BS): UTILITY OF CONTRAST-ENHANCED US WITH TIME- INTENSITY CURVES (CEUS-TIS) FOR DIAGNOSIS:
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
Procalcitonin Over the past two decades, the body of literature on the clinical usefulness of procalcitonin (PCT) in adults has grown rapidly. Although.
Testing of Patients with Chronic Hepatitis C: What do I really need? Hepatitis C Choices in Care Greg Everson, MD.
V. Petrenkiene*, D. Petrauskas L. Kupcinskas, Lithuanian University of Health sciences Clinic of Gastroenterology Kaunas Utility of non-invasive markers.
Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E,
The Progression of Liver Fibrosis is Associated with the Severity of the HIV Disease in HIV-HCV Co-infected Female Patients Mohammad K. Mohammad 1, Babu.
Protein GP73 (GOLGI PROTEIN 73) A NEW NON-INVASIVE BIOMARKER FOR ASSESSING LIVER FIBROSIS AND RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA N.K. Gatselis,
Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.
Results Table 1: Factors associated with advanced liver fibrosis in univariable analysis among 216 chronic HCV patients Background There is a clinical.
Impact of weight management in chronic HCV Egyptian patients on liver fibrosis. By: Dr. Osama A. Fekry Lecturer of CN at the AUC Head of clinical Nutrition.
Simple Noninvasive Systems Predict long-term Outcome of Patients With NAFLD Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera.
FT in diagnostic of HCV FibroTest in the diagnosis of HCV Publications on diagnostic performance.
ECML/PKDD-2005 Workshop on Discovery Challenge Guide to the Hepatitis Dataset Shusaku TsumotoShoji Hirano Department.
Kyung Hee University Hospital 대한소화기학회지 2005;45: 세대 Anti-HCV ELISA 검사의 진단 양성예측도 및 예측 인자 - Anti-HCV ELISA sample/Cutoff 비의 임상 의의를.
Henry Masur, MD Bethesda, Maryland
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Serum Dickkopf-1 ( DKK-1) and Arthritis in Systemic Lupus Erythematosus Patients S. I. Nasef, H. H. Omar Samah Ismail Nasef MD, MRCP Rheumatology UK Lecturer.
SERUM CYTOKINE EXPRESSION ACCORDING TO LAMIVUDINE THERAPY RESPONSE OF CHRONIC HEPATITIS B VIRUS INFECTION Jungyong Park 1, Younhee Park 1, Young Lan Kim.
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander-Tetri, Naga Chalasani, Arun J. Sanyal, and James E. Nelson ; for.
Reticulocyte Hb equivalent and hypochromic red cells in the study of erythropoiesis in pregnancy Eloísa Urrechaga 1, Elia Crespo 1, Luís Borque 2, Jesús.
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
External multicentric validation of a COPD detection questionnaire.
Dr. Mohammed Omar Khalifa
Journal of Hepatology ‘Accepted article’
129 patients with chronic hepatitis C
Screening Test Kit Name
Serum chronicity markers as surrogate measures of frailty
Figure 1 Proposed risk stratification for patients with NAFLD
Effect of Periodontal Therapy on GCF and Serum Levels of High-Sensitive C- reactive protein in Chronic Periodontitis Patients Alaa M Attia: Associate.
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 32, Issue 2, Pages (February 2000)
Volume 41, Issue 6, Pages (December 2004)
Serum Vascular Endothelial Growth Factor-A Level Before and After Induction Therapy in Egyptian Children with Acute Lymphoblastic Leukemia Sayed.A. Fadel1.
EVALUATION OF SOLUBLE CD14 SUBTYPE (PRESEPSIN)
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
SMOKING AND HISTOLOGICAL STAGE OF CHRONIC VIRAL HEPATITIS
4th IAS Conference , Sydney, Australia, July 2007
Predictive value of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and mean platelet volume for pelvic inflammatory disease Meryem Hocaoğlu.
Long-term impact of response to interferon-based therapy in patients with chronic HCV in relation to liver function, survival and cause of death Philip.
ARV-trial.com RUBY-I Study, cohort 2: ombitasvir/paritaprevir/ritonavir + dasabuvir + RBV for HCV genotype 1 with renal impairment Design Open label W12.
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
University of Medicine and Pharmacy “Carol Davila”, Bucharest
Clinical outcome after SVR: Veterans Affairs
BACKGROUND RESULTS OBJECTIVES METHODS CONCLUSIONS REFERENCES
Correlation of platelet indices in various disease groups with thrombocytopenia Tapasyapreeti Mukhopadhyay, Rupali Awale, Ratnaprabha Maji, Subhadra Sharma,
Presented By: Sally Saad Mandour Esawy
“Serum sP-Selectin Level and Brachial Artery Flow Mediated Dilation as Predictors of No Reflow in Patients with ST Segment Elevation Myocardial Infarction.
Brown SMN1,2, Bush A1,2, Davies JC1,2, Thursfield R1,2, Lloyd CM1
The receiver operating characteristic (ROC) curve
A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer  Gen Wang, Xiaosong.
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
A Real Life Study on Treatment of Egyptian Patients with HCV Genotype IV with Simeprevir and Sofosbuvir Prof.dr.Abdel fattah hanno Dr. Doaa al wazzan.
High sensitivity C-reactive protein and red blood cell distribution width in apparently healthy subjects with different body mass index Ei-Ei-Phyo-Myint1,
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients  Dima L. Diab, Lisa Yerian, Philip.
Volume 141, Issue 4, Pages e3 (October 2011)
Volume 143, Issue 2, Pages (August 2012)
Validation of pulse pressure variation and corrected flow time as predictors of fluid responsiveness in patients in the prone position  S.-Y. Yang, J.-K.
Volume 123, Issue 4, Pages (October 2002)
Persistent histological inflammation in autoimmune hepatitis despite
Volume 142, Issue 6, Pages e4 (May 2012)
ROC curves showing the performance of the Diabetes Risk Score in predicting diabetes in the 1987 and 1992 cohorts; follow-up of both cohorts continued.
Presentation transcript:

No conflict of interest ; RED BLOOD CELL DISTRIBUTION WIDTH (RDW)& IL1Β AS NON INVASIVE PREDICTORS OF LIVER FIBROSIS IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 4 Mahmoud El-Bendary1 , Khaled Farid1, Dina El-Barber2, Mohammed Elnagar33 1Tropical Medicine &Hepatology, Mansoura faculty of medicine 2Fever hospital, Ministry of Health, Domiatte, 3Microbiology& Immunology, Mansoura University , Mansoura, Egypt. Replace with logo Replace with logo Table [1]:Comparison between non invasive tests inearly fibrosis andadvanced fibrosis . Introduction Table[2]:ROC curve for comparison between early fibrosis & advanced fibrosis in IL1β, RDW, Platelets and RPR. Early fibrosis Late fibrosis RDW Mean±SD 113.69±2.36 18.09± 1.74 ≤ 0.0001 RPR 0.07± 0.02 0.11±0.02 IL1 β CONTROL 236.14±55.85 13.40±2.72 339.88±61.94 0.0001 FIB4 Median Minimum Maximum 1.26 0.42 55.21 2.39 0.96 4.96 <0.001 APRI 0 .77 0.25 3.67 1.42 0.66 3.47 Area under the curve Cutoff value Sensitivity Specificity PPV NPV Accuracy IL1β 90.9% (85.0%-96.8%) 294.52 86.4% 80.4% 55.8% 95.5% 82% RDW 92.92% (87.7%-98.2%) 16.5 85.9% 63.3% 95.7% 86% Platelets 75.0% (65.6%-84.4%) 196.5 81.8% 62.8% 38.3% 92.5% 67% RPR 92.92,3% (87.1%-97.6%) 0.0897 90.9% 64.5% 97.1% 87% liver biopsy is the gold standard for diagnosis of liver fibrosis but being invasive , a number of non invasive methods has been developed. Red cell distribution width(RDW) has been reported as a predictor of severity and mortality in a variety of pathological conditions including chronic hepatitis B. Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine involved in inflammation , angiogenesis and carcinogenesis. Aims & Methods The aim of this work is to use RDW& Interleukin-1β as a marker for non-invasive prediction of the stage of hepatic fibrosis in patients with chronic hepatitis C .100 patients with chronic hepatitis C were subjected to routine laboratory & radiological investigations in addition to using KX-21 Sysmex automated hematology analyzer to measure RDW& RPR (RDW%/Platelet ratio). Comparing with other biomarkers of liver fibrosis like APRI (AST-to-Platelet ratio index) FIB-4 equation ( using platelet count, AST, ALT, age) to perform this test. PCR HCV RNA ,genotyping & liver biopsy ( using METAVIR scoring system where cases were classified into early fibrosis (F1+F2):68 patients & late fibrosis (F3+F4) :32 patients]were done. Interleukin-1β was assayed using ELISA for all patients in addition to 20healthy subject as a control group. In conclusion the area under the ROC curve for IL1β,RDW& RPR were excellent but for platelets, FIB-4 & APRI were fair. when applying regression analysis it was found that the RDW (OR:3.903, 95% CI :1.538-9.904) while IL1β (OR:1.057, 95% CI : 1.012-1.104) & Platelets (OR:0953 , 95% CI :0.913-0.995), so as the level of RDW & IL1β increase by one unit the risk late fibrosis will increase by 3.9 & 1.057 on the other hand when the platelets increase by one unit the risk of late fibrosis will decrease by 0.953. . By applying roc curve it was found that the cut off value of RDW was 16.5, with sensitivity 86.4 % specificity 85.9 % & accuracy 86% & the cut off value of the platelets was 196 ,5 with sensitivity 81.8 %, specificity 62.8% accuracy 67%, while RPR cut off value was 0.0897 with sensitivity 90.9 %, specificity 85.9 % & accuracy 87% .As regard APRI test it was found that the cut off value was 40.5with sensitivity 72.7%, specificity 66.7% & accuracy 68% While FIB-4equation showed cut off value 1.685 with sensitivity 77.3 %, specificity 66.7% and accuracy 69% the cut off value of IL1β was 294.52 pg/ml. with sensitivity 86.4% specificity 80.4% & accuracy 82%. Conclusion Results RDW , RPR& IL1β may be used as simple, non-invasive predictors of advanced fibrosis in patients with with chronic HCV genotype-4.   RDW & RPR & IL-1β was significantly higher in patients with late fibrosis > early fibrosis (P <0.0001) while platelets count was significantly lower in late fibrosis > early fibrosis (p< 0.001). No conflict of interest Poster No: P:01 Mahmoud El-Bendary - Mansoura Faculty of Mediine - Egypt (Email: mmelbendary@gmail.com-- cell phone :+201002592205 c P:01